Seyran Yiğit

643 total citations
43 papers, 433 citations indexed

About

Seyran Yiğit is a scholar working on Oncology, Pathology and Forensic Medicine and Reproductive Medicine. According to data from OpenAlex, Seyran Yiğit has authored 43 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 12 papers in Reproductive Medicine. Recurrent topics in Seyran Yiğit's work include Ovarian cancer diagnosis and treatment (11 papers), Cancer and Skin Lesions (7 papers) and Breast Cancer Treatment Studies (7 papers). Seyran Yiğit is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Cancer and Skin Lesions (7 papers) and Breast Cancer Treatment Studies (7 papers). Seyran Yiğit collaborates with scholars based in Türkiye, United Kingdom and France. Seyran Yiğit's co-authors include Ali Baloğlu, Lütfiye Demir, Mustafa Oktay Tarhan, Ahmet Alacacıoğlu, Yüksel Küçükzeybek, Işıl Somali, Çiğdem Erten, Ahmet Dirican, Hülya Ellıdokuz and Ayşegül Sarı and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Emergency Medicine and Clinical & Experimental Metastasis.

In The Last Decade

Seyran Yiğit

41 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seyran Yiğit Türkiye 14 181 95 93 84 76 43 433
Christina Kaiser Germany 11 143 0.8× 50 0.5× 89 1.0× 78 0.9× 82 1.1× 25 401
S. Loibl Germany 10 254 1.4× 227 2.4× 96 1.0× 123 1.5× 93 1.2× 30 516
Loes Kooreman Netherlands 15 135 0.7× 90 0.9× 202 2.2× 92 1.1× 74 1.0× 52 558
Alessandra Bologna Italy 12 288 1.6× 188 2.0× 62 0.7× 74 0.9× 118 1.6× 37 421
Jenny Brändstedt Sweden 11 165 0.9× 72 0.8× 120 1.3× 58 0.7× 161 2.1× 15 415
Xiaoyi Duan China 12 128 0.7× 46 0.5× 56 0.6× 104 1.2× 63 0.8× 31 371
Laura Matteucci Italy 6 141 0.8× 55 0.6× 78 0.8× 38 0.5× 69 0.9× 15 272
Amy Guppy United Kingdom 6 105 0.6× 112 1.2× 36 0.4× 38 0.5× 80 1.1× 10 298
Ana T. Nunes United States 11 275 1.5× 52 0.5× 52 0.6× 70 0.8× 120 1.6× 19 455
P. Athanassiades Greece 12 139 0.8× 61 0.6× 71 0.8× 93 1.1× 179 2.4× 47 470

Countries citing papers authored by Seyran Yiğit

Since Specialization
Citations

This map shows the geographic impact of Seyran Yiğit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seyran Yiğit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seyran Yiğit more than expected).

Fields of papers citing papers by Seyran Yiğit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seyran Yiğit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seyran Yiğit. The network helps show where Seyran Yiğit may publish in the future.

Co-authorship network of co-authors of Seyran Yiğit

This figure shows the co-authorship network connecting the top 25 collaborators of Seyran Yiğit. A scholar is included among the top collaborators of Seyran Yiğit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seyran Yiğit. Seyran Yiğit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yiğit, Seyran, et al.. (2021). Angiomyofibroblastoma of the uterine cervix in a patient with triple negative breast cancer: a case report. 3(2). 181–184. 2 indexed citations
2.
Etıt, Demet, et al.. (2021). Clinicopathological features of mammary Paget’s disease: a single-center experience in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(6). 2994–3000.
3.
Yiğit, Seyran, et al.. (2020). Epithelioid trophoblastic tumor in a postmenopausal woman: A case report and review of the literature in the postmenopausal group. SHILAP Revista de lepidopterología. 63(5). 98–98. 4 indexed citations
4.
Bayoğlu, İbrahim Vedat, Yüksel Küçükzeybek, Ahmet Alacacıoğlu, et al.. (2019). The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer.. PubMed. 22(4). 947–952. 1 indexed citations
6.
Yiğit, Seyran, et al.. (2019). Androgen Receptor Expression in Adenoid Cystic Carcinoma of Breast: A Subset of Seven Cases. SHILAP Revista de lepidopterología. 16(1). 44–47. 7 indexed citations
7.
Calibasi‐Kocal, Gizem, et al.. (2018). SELDI-TOF-MS Profiling of Metastatic Phenotype in Histopathological Subtypes of Breast Cancer. Current Proteomics. 15(3). 214–220. 1 indexed citations
8.
Yiğit, Seyran, et al.. (2018). Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases. Journal of the Turkish-German Gynecological Association. 19(3). 132–136. 2 indexed citations
9.
Acar, Turan, Ercüment Tarcan, Mehmet Hacıyanlı, et al.. (2015). How to approach phyllodes tumors of the breast?. Turkish Journal of Surgery. 31(4). 197–201. 8 indexed citations
10.
Yiğit, Seyran, et al.. (2014). Primary mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH – and review of the literature. Polish Journal of Pathology. 1(1). 70–73. 17 indexed citations
11.
Demir, Lütfiye, Seyran Yiğit, Murat Akyol, et al.. (2014). Hormone Receptor, HER2/NEU and EGFR Expression in Ovarian Carcinoma - is here a Prognostic Phenotype?. Asian Pacific Journal of Cancer Prevention. 15(22). 9739–9745. 18 indexed citations
12.
Somali, Işıl, Mustafa Oktay Tarhan, Seyran Yiğit, et al.. (2013). Clinicopathologic and Demographic Evaluation of Triple-Negative Breast Cancer Patients among a Turkish Patient Population: a Single Center Experience. Asian Pacific Journal of Cancer Prevention. 14(10). 6013–6017. 16 indexed citations
13.
Demir, Lütfiye, Seyran Yiğit, Hülya Ellıdokuz, et al.. (2013). Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clinical & Experimental Metastasis. 30(8). 1047–1062. 50 indexed citations
14.
Tarhan, Mustafa Oktay, Lütfiye Demir, Işıl Somali, et al.. (2012). The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival. Clinical & Experimental Metastasis. 30(2). 201–213. 19 indexed citations
15.
Kılçıksız, Sevil, et al.. (2012). Cancer in elderly: A study of hospital-based cancer registry in the Western Turkey.. PubMed. 16(1). 57–60. 2 indexed citations
16.
Yiğit, Seyran, et al.. (2012). Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases. Pathology - Research and Practice. 208(3). 147–150. 3 indexed citations
17.
Rezanko, Türkan, et al.. (2012). Lymphoma of the cervix: A diagnostic pitfall on cervicovaginal smear. Journal of Cytology. 29(3). 213–213. 12 indexed citations
18.
Atahan, Kemal, et al.. (2011). The Value of Serum Biomarkers (Bc1, Bc2, Bc3) in the Diagnosis of Early Breast Cancer. International Journal of Medical Sciences. 8(2). 148–155. 13 indexed citations
19.
Derıcı, Hayrullah, et al.. (2007). Nonpalpabl meme lezyonlarının stereotaktik işaretlenmesi ve cerrahi eksizyonu. 3(1). 10–13. 1 indexed citations
20.
Atahan, Kemal, et al.. (2007). Carcinosarcoma of the breast. SHILAP Revista de lepidopterología. 3(2). 85–86. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026